Amendment to Schedule 13D Filing for Smith & Nephew plc
2026-03-16SEC Filing SCHEDULE 13D/A (0000902664-26-001613)
This filing is an Amendment No. 4 to the Schedule 13D, originally filed on July 9, 2024, by Cevian Capital II GP LTD regarding the Ordinary shares of Smith & Nephew plc. As of March 16, 2026, Cevian Capital II GP LTD beneficially owns 81,687,136 Ordinary Shares, representing 9.6% of the class. These shares were acquired for an aggregate consideration of approximately USD $1,095,708,998, funded by the Cevian Funds' general working capital. The filing details transactions within the past sixty days, including purchases made between January 20, 2026, and March 13, 2026. The total number of outstanding Ordinary Shares is reported as 849,889,305 as of February 28, 2026.
Related industry:Medical Devices
Source:Original SEC Document β